AbbVie Inc. Price Today
AbbVie Inc.
ABBV
Healthcare
$245.22B
💰
Market Cap
28.6
💸
Price to Earnings
$4.9
🎉
EPS
+72
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
5 |
Hold |
14 |
Sell |
0 |
Strong Sell |
0 |
ABBV Price Forecast Target
138.9 👉 193.3 +39%
ABBV EPS Forecast
4.9 👉 10.4 +115%
Financials
Profit Margin
12 %
Revenue Growth
-6.0 %
Dividend
$ 5.92
Held Percent
0.1% - Insiders
71.4% - Institutions
28.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $22.1B
-
💰 Blackrock Inc. $19.3B
-
💰 State Street Corporation $10.9B
-
💰 JP Morgan Chase & Company $7.9B
-
💰 Capital International Investors $6.0B
Stock Ideas
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…📮FAQ
Some Frequently Asked Questions.
The AbbVie Inc. industry is Drug Manufacturers - General
The AbbVie Inc. sector is Healthcare
The AbbVie Inc. forecasted predicted Price to Earnings PE ratio is 13.3
The AbbVie Inc. Price to Earnings PE ratio is 28.6
The Market Capitalization of AbbVie Inc. is $245.22B
There are total of 1762275557 float shares with 71.4% held by Institutions and 0.1% held by insiders
The MAbbVie Inc. forecasted Earnings per Share EPS is $10.4
The AbbVie Inc. Earnings per Share EPS is 4.9
The AbbVie Inc. company has $41527000000 gross profits with 12 profit margins
The AbbVie Inc. Earnings Growth is -0.548% with -0.55% quarterly earnings growth
The AbbVie Inc. Revenue is $55138000896 with -0.06 revenue growth
The price target for AbbVie Inc. stock is $193.3 for the high target and $127.3 for the low target
The consensus analyst recommendations for AbbVie Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AbbVie Inc. is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 5
- Hold: 14
- Sell: 0
- Strong Sell: 0
The Beta of AbbVie Inc. is 0.5
The dividend of AbbVie Inc. is $5.92
The dividend yield of AbbVie Inc. is 0.042600002%
The biggest institutional and mutual fund holders of AbbVie Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- JP Morgan Chase & Company
The AbbVie Inc. ESG Score is 72, with the following breakdown:
- E: 1.12
- S: 16.77
- G: 9.95